FeaturesSignalPricingFounders
Log inGet started free
AV

Avalon Ventures

Venture CapitalActive

Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.

La Jolla, United StatesFounded 2008avalon-ventures.com/
166
Investments
10
Exits
AUM
6.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Avalon Ventures.

Get started free

Investment Thesis & Strategy

Avalon Ventures invests in early-stage information technology and life sciences companies. They typically invest in companies that are developing innovative technologies in these sectors.

Investment Activity

Deals per year over the last 12 years

2
2003
0
2004
2
2005
1
2006
1
2007
0
2008
1
2009
0
2010
0
2011
0
2012
0
2013
1
2014

Portfolio Companies

Selected investments from their portfolio of 166 companies

X
Xencor
Biotech · Series A, 0
Active
O
Onyx Pharmaceuticals
Biotech · Series A, 0
Active
N
NextWave Wireless
Other · Series A, 0
Active
S
Sequenom
Biotech · Series A, 0
Active
C
Corvus Pharmaceuticals
Biotech · Series A, 2014
Active
R
Roka Bioscience
Biotech · Series A, 2009
Active
F
Fate Therapeutics
Biotech · Series A, 2007
Active
S
Symphogen
Biotech · Series A, 2006
Active
R
Receptos
Biotech · Series A, 2005
Active
C
Conatus Pharmaceuticals
Biotech · Series A, 2005
Active
A
Ambit Biosciences
Biotech · Series A, 2003
Active
A
Achaogen
Biotech · Series A, 2003
Active

Notable Exits

CompanyTypeYearValue / Acquirer
ViaCyteAcquisition2022
SymphogenAcquisition2020$276M
Kura OncologyIPO2014
AchaogenIPO2014
Ambit BiosciencesAcquisition2014$410M
Onyx PharmaceuticalsAcquisition2013$10.4B
Fate TherapeuticsIPO2013
Ardea BiosciencesAcquisition2012$320M
SequenomIPO2000
IlluminaIPO2000

Frequently Asked Questions

Avalon Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors